# FDA Inspection 1036266 - OneBlood, Inc. - November 15, 2017

Source: https://www.keypedia.com/records/fda_inspections/oneblood-inc/7bc104ce-c64b-4e48-a30e-3a89f9b48d82
Source feed: FDA_Inspections

> FDA Inspection 1036266 for OneBlood, Inc. on November 15, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1036266
- Company Name: OneBlood, Inc.
- Inspection Date: 2017-11-15
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1312740 - 2026-04-09](https://www.keypedia.com/records/fda_inspections/oneblood-inc/818fa0c6-6bb3-4515-bd93-a1d0f1692e4a)
- [FDA Inspection 1155033 - 2021-09-17](https://www.keypedia.com/records/fda_inspections/oneblood-inc/0e2a6669-a1c4-4c9a-a9e8-bee5abb1bfd5)
- [FDA Inspection 1155033 - 2021-09-17](https://www.keypedia.com/records/fda_inspections/oneblood-inc/81ba2092-8727-4dea-a2d4-2fc14998808f)
- [FDA Inspection 969010 - 2016-02-12](https://www.keypedia.com/records/fda_inspections/oneblood-inc/fbf27377-9868-49c1-873c-5b6f412c28a1)
- [FDA Inspection 888899 - 2014-07-24](https://www.keypedia.com/records/fda_inspections/oneblood-inc/55f273dc-9ae5-47aa-bb4c-951b4a52fdd0)

Company: https://www.keypedia.com/companies/oneblood-inc/2f8522cb-2176-47aa-b26c-9c61dd3d44eb

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d